in genotype distribution. The 2-2 genotype was present in three out of 26 patients with dyskinesia (11.5%) vs eight out of 30 patients without dyskinesia (26.7%; P = 0.19). Due to the lower frequency of the 2.2 genotype, together with an over-representation of the 1-2 genotype among the dyskinesia-positive subjects (see above), the overall distribution (2 × 3 table) of the 1-1, 1-2 and 2-2 genotypes was almost significantly different in the dyskinesia-positive vs dyskinesia-negative schizophrenic patients (P = 0.056 by Fisher exact test). Our present data indicate that the Gly-9 variant (allele 2) is more frequent in this Indian population as compared to its frequency in other Asian as well as Caucasian populations. 15 We were not able to demonstrate any association between the Ser9Gly DRD3 genotype and the presence of dyskinesia in drug-naive schizophrenic patients. Due to the low number of subjects, however, with a corresponding insufficient statistical power, the risk of a type 2 (false negative) error is high. Unfortunately, we have not been able to increase the size of our unique sample. The hypothesis that schizophrenic patients homozygous for the Gly-9 allele represent a certain phenotype with a high prevalence of dyskinesia can therefore not be excluded. We anticipate that the inclusion and examination of numerous drug-naive schizophrenic patients with long-lasting illness in general may prove difficult. Still, we would like to challenge other research groups to extend our pilot study, to further examine whether the proposed predisposing role of the Ser9Gly DRD3 polymorphism in dyskinesia development is linked to the use of classical neuroleptic drugs or just appears as an association to a specific schizophrenia phenotype that expresses dyskinesia. A reliable answer, positive or negative, should be highly important. DRD4 and DAT1 as modifying genes in alcoholism: interaction with novelty seeking on level of alcohol consumption SIR -We have presented data on allele and genotype frequencies of the DRD4 exon 3 polymorphism in Brazilian alcoholics and control subjects, 1 and the association of the DRD4 seven-repeat allele containing genotypes with personality dimensions in alcoholics.
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The reason for examining these genes simultaneously is that both have been associated to conditions involving impulsivity or hyperactivity tendencies, especially attention-deficit hyperactivity disorder (ADHD) 6, 7 and novelty seeking, 8 which are relevant to the predisposition to substance abuse. 9 We hypothesized that both genes could interact with nov- elty seeking on the level of alcohol consumption and the severity of alcoholism.
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DAT1 genotype and allele frequencies in the same samples of alcoholics (n = 114) and controls (n = 112) studied for DRD4 are shown in Table 1 . Allele and genotype frequencies in alcoholics and controls did not differ significantly. No significant differences were observed between alcoholics with and without the DRD4 7/* or DAT1 10,10 genotypes on the mean values of novelty seeking, consumption level and severity scores.
The interaction terms of the DRD4 7/* or DAT1 10,10 genotypes with novelty seeking did not have significant regression coefficients on the severity scores. However, significant interactive effects were detected for the DRD4 7/* and DAT1 10,10 genotypes with novelty seeking on alcohol consumption ( Table 2 ). The variance proportion explained by the interaction terms was 6.6% for the DRD4 7/* (P = 0.005) and 4.9% for the DAT1 10,10 (P = 0.04). The interaction effects were further analyzed by partial correlations of novelty seeking with consumption level. The correlations in alcoholics with the DRD4 7/* and DAT1 10,10 genotypes accounted for 20% (P = 0.008) and 8% (P = 0.002) of the variance in consumption level, respectively. In alcoholics with other genotypes, these correlations were not significant.
If Bonferroni correction were applied to the tests presented here, the interaction effect between DAT1 and novelty seeking would not be significant. However, since both DAT1 and DRD4 have been shown to be associated with the same behavior characteristics, we think that all these results should be taken into consideration.
According to a widely referred model that links personality to alcoholism, 10 novelty seeking would be the personality dimension responsible for individual differences in brain systems modulating the activation of behavioral responses to the effects of alcohol. The possible presence of an interaction effect between DRD4 and DAT1 genotypes with novelty seeking on the level of consumption suggests that these genotypes may increase the alcohol-seeking behavior in high novelty seeking individuals, supporting that model.
10
Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake SIR -Anorexia nervosa (AN) is regarded either as a primary eating disorder, or as a mood disorder leading to decrease in food intake. The serotonergic system is involved in both kinds of disorders. A functional polymorphism of the 5-HTT gene is located in the promoter region and consists of a 44-bp insertion or deletion. 1 The transcriptional activity of the short (S) variant is half that of the long (L) one, leading to a decrease in 5-HTT expression and finally in 5-HT uptake by 50%. 2 The aim of our study was to determine whether this polymorphism could influence eating behavior and food intake. Three groups of population were studied: (1) AN patients (65 women, two men; age: 24.3 ± 6.5 years) hospitalized in the Nutrition Department of Bichat Hospital in Paris, fulfilling the DSM-IV criteria for AN, having severe malnutrition (BMI: 13.6 ± 1.9 kg m −2 ) and a restrictive form of the disease. (2) Normal weight controls (84 women, 64 men; age:
41.2 ± 4.1, BMI: 22.6 ± 2.1 kg m −2 ) drawn from the 
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Stanislas Study, composed of volunteers for a free health examination in the Nancy region. ; among these, 286 from Paris, 72 from Nancy). All subjects were French Caucasians. The spontaneous dietary intakes were assessed using the diet history method in Paris 4 and the 3-day record method in Nancy. 5 The polymorphism of the 5-HTT gene was analyzed by PCR amplification. 6 The SS genotype was significantly more frequent in AN patients than in other groups (Table 1) , frequency of the S allele being higher in the AN group (51.5%) and lower in the overweight subjects (39.8%) when compared to normal weight controls (44.6%) (P Ͻ 0.05). Even after exclusion of the AN group, the SS genotype was associated with lower energy intake ( Table 1 ). This was due to lower intakes of all the main nutrients, but only the difference in carbohydrates was statistically significant (Table 1 ). This can be related to the formerly described role of 5-HT in carbohydrate intake regulation, 7 even if it has now been shown that serotonin has suppressive effects on consumption of all rewarding substances.
In other studies of this polymorphism in anorexic patients, no significant association was found. [8] [9] [10] Our result might be a false positive because the AN sample is small. Nevertheless, in the more recent studies, 8, 9 an excess of S allele was found in AN although this was not statistically significant. The discrepancy with Hinney et al 10 could be due to a different selection of patients. In Hinney et al, 10 patients were younger
